Elevated level of circulating CD4⁺Helios⁺FoxP3⁺ cells in primary Sjogren’s syndrome patients

References

• Fox RI. Sjögren's syndrome. Lancet. 2005;366:321–31.
   PubMed Web of Science ®Google Scholar
• Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum. 2000;29:296–304.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:554–8.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising Foxp3-expressing CD25 + CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345–52.
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, et al. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun. 2005;24:235–42.
   PubMed Web of Science ®Google Scholar
• Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol. 2005;175:8392–400.
   PubMed Web of Science ®Google Scholar
• Li X, Li X, Qian L, Wang G, Zhang H, Wang X, et al. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. J Rheumatol. 2007;34:2438–45.
   PubMed Web of Science ®Google Scholar
• Liu MF, Lin LH, Weng CT, Weng MY. Decreased CD4 + CD25 + bright T cells in peripheral blood of patients with primary Sjogren's syndrome. Lupus. 2008;17:34–9.
   PubMed Web of Science ®Google Scholar
• Christodoulou MI, Kapsogeorgou EK, Moutsopoulos NM, Moutsopoulos HM. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol. 2008;173:1389–96.
   PubMed Web of Science ®Google Scholar
• Szodoray P, Papp G, Horvath IF, Barath S, Sipka S, Nakken B, et al. Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome. Clin Exp Immunol. 2009;157:343–9.
   PubMed Web of Science ®Google Scholar
• Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, Forsea AM, et al. Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity. 2008;42:41–9.
   Web of Science ®Google Scholar
• Sarigul M, Yazisiz V, Başsorgun CI, Ulker M, Avic AB, Erbasan F, et al. The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome. Lupus. 2010;19:138–45.
   PubMed Web of Science ®Google Scholar
• Furuzawa-Carballeda J, Hernández-Molina G, Lima G, Rivera-Vicencio Y, Férez-Blando K, Llorente L. Peripheral regulatory cells immunophenotyping in primary Sjogren's syndrome: a cross-sectional study. Arthritis Res Ther. 2013;15:R68.
   PubMed Web of Science ®Google Scholar
• Alunno A, Petrillo MG, Nocentini G, Bistoni O, Bartoloni E, Caterbi S, et al. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. Rheumatology (Oxford). 2013;52:1387–96.
   PubMed Web of Science ®Google Scholar
• Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Mirabelli G, et al. T regulatory and T helper 17 cells in primary Sjögren’s syndrome: facts and perspectives. Mediators Inflamm. 2015;2015:1–10.
   Google Scholar
• Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4 + CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245–53.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE. Clinical significance of increased CD4 + CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis. 2008;67:1037–40.
   PubMed Web of Science ®Google Scholar
• Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, Tang FL, et al. Are CD4+ CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells. Arthritis Res Ther. 2009;11:1–9.
   Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.
   PubMed Web of Science ®Google Scholar
• Wang J, Ioan‐Facsinay A, Van der Voort EIH, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol. 2007;37:129–38.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22:329–41.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433–41.
   PubMed Web of Science ®Google Scholar
• Alexander T, Sattler A, Templin L, Kohler S, Groß C, Meisel A, et al. Foxp3+ Helios + regulatory T cells are expanded in active systemic lupus erythematosus. Ann Rheum Dis. 2013;72:1549–58.
   PubMed Web of Science ®Google Scholar
• Takatori H, Kawashima H, Matsuki A, Meguro K, Tanaka S, Iwamoto T, et al. Helios enhances Treg cell function in cooperation with FoxP3. Arthritis Rheum. 2015;67:1491–502.
   PubMed Web of Science ®Google Scholar
• Chen X, Vander Lugt M, Szabolcs P. Deficiency of Foxp3/Helios co-expressing regulatory T-cells correlates with clinical acitvity in autoimmunity (HUM7P. 316). J Immunol. 2014;192:184.25–.25.
   Web of Science ®Google Scholar
• Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen HR, Bruno TC, et al. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol. 2010;47:1595–600.
   PubMed Web of Science ®Google Scholar
• Zabransky DJ, Nirschl CJ, Durham NM, Park BV, Ceccato CM, Bruno TC, et al. Phenotypic and functional properties of Helios + regulatory T cells. PLoS One. 2012;7:65.
   Web of Science ®Google Scholar
• Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest. 2007;117(5):1119–27.
   PubMed Web of Science ®Google Scholar
• Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5–17.
   PubMed Web of Science ®Google Scholar
• Roescher N, Tak PP, Illei GG. Cytokines in Sjögren's syndrome: potential therapeutic targets. Ann Rheum Dis. 2010;69:945–8.
   PubMed Web of Science ®Google Scholar
• Szodoray P, Alex P, Brun JG, Centola M, Jonsson R. Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scand J Immunol. 2004;59(6):592–9.
   PubMed Web of Science ®Google Scholar
• Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4 + CD25- cells to CD25 + Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007;178(4):2018–27.
   PubMed Web of Science ®Google Scholar
• Horwitz DA, Zheng SG, Wang J, Gray JD. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3 + CD4+ Treg. Eur J Immunol. 2008;38(4):912–15.
   PubMed Web of Science ®Google Scholar
• Maria NI, van Helden‐Meeuwsen CG, Brkic Z, Paulissen SM, Steenwijk EC, et al. Increased Tregs associated with elevated Indoleamine‐2, 3‐dioxygenase activity and an imbalanced Kynurenine pathway in IFNpositive primary Sjögren's syndrome. Arthritis Rheumatol. 2016;68(7):1688–99.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hong J, Sun W, Xu G, Li N Chen X, et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J Clin Invest 2006;116(9):2434–41.
   PubMed Web of Science ®Google Scholar
• Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A Theander E, et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis. 2010;69:1103–9.
   PubMed Web of Science ®Google Scholar
• Seror R, Ravaud P, Mariette X, Bootsma H, Theander E Hansen A, et al. EULAR Sjogren's syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis. 2011;70:968–72.
   PubMed Web of Science ®Google Scholar
• Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol. 2009;182:1689–95.
   PubMed Web of Science ®Google Scholar